Variant report

Variant	esv3390112
Chromosome Location	chr21:47516949-47519497
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:199)
CpG islands
(count:366)
Chromatin interactive
region (count:1)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:199 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CCNT2	chr21:47517952-47518120	K562	blood:	n/a	n/a
2	CHD1	chr21:47517617-47521975	IMR90	lung:	n/a	chr21:47518570-47518580 chr21:47518877-47518887
3	CHD2	chr21:47517489-47517580	HepG2	liver:	n/a	n/a
4	CTCF	chr21:47519340-47519490	AG10803	skin:	n/a	chr21:47519453-47519466
5	CTCF	chr21:47519380-47519530	HBMEC	blood vessel:	n/a	chr21:47519453-47519466
6	CTCF	chr21:47519482-47519489	K562	blood:	n/a	n/a
7	CTCF	chr21:47519438-47519477	K562	blood:	n/a	chr21:47519453-47519466
8	CTCF	chr21:47519380-47519530	HCM	heart:	n/a	chr21:47519453-47519466
9	CTCF	chr21:47519400-47519550	AG09319	gingival:	n/a	chr21:47519453-47519466
10	CTCF	chr21:47517900-47518050	HA-sp	spinal cord:	n/a	n/a
11	CTCF	chr21:47517940-47518090	WERI-Rb-1	eye:	n/a	n/a
12	CTCF	chr21:47517903-47518136	K562	blood:	n/a	n/a
13	CTCF	chr21:47517867-47518028	SK-N-SH_RA	brain:	n/a	n/a
14	CTCF	chr21:47517840-47517990	HPF	lung:	n/a	n/a
15	CTCF	chr21:47517900-47518050	HRE	kidney:	n/a	n/a
16	CTCF	chr21:47517740-47517890	AG04449	skin:	n/a	chr21:47517795-47517808
17	CTCF	chr21:47517940-47518090	HMF	breast:	n/a	n/a
18	CTCF	chr21:47517840-47517990	BJ	skin:	n/a	n/a
19	CTCF	chr21:47519400-47519550	AG09309	skin:	n/a	chr21:47519453-47519466
20	CTCF	chr21:47519360-47519510	HAc	cerebellar:	n/a	chr21:47519453-47519466
21	CTCF	chr21:47517933-47518055	Gliobla	brain:	n/a	n/a
22	CTCF	chr21:47517940-47518090	HPF	lung:	n/a	n/a
23	CTCF	chr21:47517940-47518090	HVMF	connective:	n/a	n/a
24	CTCF	chr21:47517840-47517990	K562	blood:	n/a	n/a
25	CTCF	chr21:47517900-47518050	NHDF-neo	bronchial:	n/a	n/a
26	CTCF	chr21:47519400-47519550	SK-N-SH_RA	brain:	n/a	chr21:47519453-47519466
27	CTCF	chr21:47519420-47519570	HMF	breast:	n/a	chr21:47519453-47519466
28	CTCF	chr21:47519420-47519570	AG09319	gingival:	n/a	chr21:47519453-47519466
29	CTCF	chr21:47517880-47518030	Caco-2	colon:	n/a	n/a
30	CTCF	chr21:47517893-47518058	Pancreas_OC	pancreas:	n/a	n/a
31	CTCF	chr21:47519420-47519570	HVMF	connective:	n/a	chr21:47519453-47519466
32	CTCF	chr21:47519360-47519510	HCM	heart:	n/a	chr21:47519453-47519466
33	CTCF	chr21:47519340-47519490	RPTEC	kidney:	n/a	chr21:47519453-47519466
34	CTCF	chr21:47519380-47519530	HRE	kidney:	n/a	chr21:47519453-47519466
35	CTCF	chr21:47517859-47518098	K562	blood:	n/a	n/a
36	CTCF	chr21:47517900-47518050	HCM	heart:	n/a	n/a
37	CTCF	chr21:47519301-47519640	IMR90	lung:	n/a	chr21:47519621-47519634 chr21:47519453-47519466
38	CTCF	chr21:47517900-47518050	HCPEpiC	choroid plexus:	n/a	n/a
39	CTCF	chr21:47519420-47519570	AG04449	skin:	n/a	chr21:47519453-47519466
40	CTCF	chr21:47517820-47517970	AG09309	skin:	n/a	n/a
41	CTCF	chr21:47519340-47519490	HPAF	blood vessel:	n/a	chr21:47519453-47519466
42	CTCF	chr21:47519400-47519550	BJ	skin:	n/a	chr21:47519453-47519466
43	CTCF	chr21:47518140-47518290	AG04449	skin:	n/a	chr21:47518242-47518255
44	CTCF	chr21:47519444-47519506	H1-hESC	embryonic stem cell:	n/a	chr21:47519453-47519466
45	CTCF	chr21:47517940-47518090	AG09319	gingival:	n/a	n/a
46	CTCF	chr21:47517967-47518022	MCF-7	breast:	n/a	n/a
47	CTCF	chr21:47519440-47519590	SK-N-SH_RA	brain:	n/a	chr21:47519453-47519466
48	CTCF	chr21:47517940-47518090	HBMEC	blood vessel:	n/a	n/a
49	CTCF	chr21:47519420-47519570	BJ	skin:	n/a	chr21:47519453-47519466
50	CTCF	chr21:47517820-47517970	GM12870	blood:	n/a	n/a

(count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr21:47519444-47519494	SAEC	small airway:	n/a
2	chr21:47518747-47518797	HRCEpiC	kidney:	n/a
3	chr21:47518747-47518797	HEK293	kidney:	embryo
4	chr21:47519444-47519494	GM12878	blood:	n/a
5	chr21:47517690-47517740	HCPEpiC	choroid plexus:	n/a
6	chr21:47518998-47519048	HRPEpiC	eye:	n/a
7	chr21:47519444-47519494	Hela-S3	cervix:	n/a
8	chr21:47518747-47518797	AG04449	skin:	fetal
9	chr21:47519444-47519494	SKMC	muscle:	n/a
10	chr21:47517484-47517534	SKMC	muscle:	n/a
11	chr21:47518747-47518797	PFSK-1	brain:	n/a
12	chr21:47517484-47517534	GM12878	blood:	n/a
13	chr21:47518998-47519048	GM06990	blood:	n/a
14	chr21:47519444-47519494	H1-hESC	embryonic stem cell:	embryo
15	chr21:47519444-47519494	GM12891	blood:	n/a
16	chr21:47519444-47519494	U87	brain:	n/a
17	chr21:47517690-47517740	HRE	kidney:	n/a
18	chr21:47519444-47519494	NHDF-neo	bronchial:	n/a
19	chr21:47518747-47518797	ovcar-3	ovarian:	n/a
20	chr21:47517690-47517740	NH-A	brain:	n/a
21	chr21:47517690-47517740	U87	brain:	n/a
22	chr21:47517484-47517534	ovcar-3	ovarian:	n/a
23	chr21:47518747-47518797	GM12878	blood:	n/a
24	chr21:47518747-47518797	AoSMC	blood vessel:	n/a
25	chr21:47518068-47518118	U87	brain:	n/a
26	chr21:47517484-47517534	ProgFib	skin:	n/a
27	chr21:47517484-47517534	IMR90	lung:	fetal
28	chr21:47518998-47519048	Jurkat	blood:	n/a
29	chr21:47517690-47517740	GM06990	blood:	n/a
30	chr21:47518747-47518797	SK-N-MC	brain:	n/a
31	chr21:47518998-47519048	AG09309	skin:	n/a
32	chr21:47519444-47519494	HPAEpiC	pulmonary alveolar:	n/a
33	chr21:47518747-47518797	GM06990	blood:	n/a
34	chr21:47517484-47517534	U87	brain:	n/a
35	chr21:47517484-47517534	AG09309	skin:	n/a
36	chr21:47518747-47518797	NHBE	bronchial:	n/a
37	chr21:47518747-47518797	HPAEpiC	pulmonary alveolar:	n/a
38	chr21:47518747-47518797	U87	brain:	n/a
39	chr21:47519444-47519494	GM19239	blood:	n/a
40	chr21:47518068-47518118	PrEC	prostate:	n/a
41	chr21:47519444-47519494	RPTEC	kidney:	n/a
42	chr21:47518747-47518797	CMK	blood:	n/a
43	chr21:47518747-47518797	Hepatocyte	liver:	n/a
44	chr21:47517484-47517534	T-47D	breast:	n/a
45	chr21:47518068-47518118	NB4	blood:	n/a
46	chr21:47517484-47517534	HAEpiC	amniotic membrane:	n/a
47	chr21:47517484-47517534	A549	lung:	n/a
48	chr21:47519444-47519494	IMR90	lung:	fetal
49	chr21:47517690-47517740	HRPEpiC	eye:	n/a
50	chr21:47519444-47519494	HRE	kidney:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr21:47393279..47394087-chr21:47517478..47517993,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FTCD-1	chr21:47517386-47517444	XLOC_014132

No data

Variant related genes	Relation type
ENSG00000227438	TF binding region
COL6A2	TF binding region
ENSG00000227438	CpG island
COL6A2	CpG island

Extended variants
information (count: 77 )
Associated
traits (count: 36 )

Variant overlapped rSNPs/rCNVs (count:77 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs551867395	chr21:47516954-47516955	Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs199779224	chr21:47516965-47516966	Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs552797492	chr21:47516966-47516967	Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs556519675	chr21:47516967-47516968	Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs3057143	chr21:47516971-47516972	Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs552465282	chr21:47517001-47517002	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs557545033	chr21:47517074-47517075	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs561984293	chr21:47517087-47517088	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs564209326	chr21:47517088-47517089	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs138000723	chr21:47517105-47517106	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs572155961	chr21:47517136-47517137	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs545686261	chr21:47517148-47517149	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs1475915	chr21:47517157-47517158	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs577286551	chr21:47517200-47517201	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs544593762	chr21:47517210-47517211	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs539524300	chr21:47517265-47517266	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs530408110	chr21:47517272-47517273	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs11700580	chr21:47517353-47517354	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs183859269	chr21:47517367-47517368	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs527852361	chr21:47517412-47517413	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
21	rs552519330	chr21:47517451-47517452	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
22	rs371581471	chr21:47517466-47517467	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
23	rs11700478	chr21:47517512-47517513	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region CpG island	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs150030303	chr21:47517513-47517514	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
25	rs549953978	chr21:47517539-47517540	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs9975112	chr21:47517544-47517545	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
27	rs11700479	chr21:47517551-47517552	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs529522870	chr21:47517558-47517559	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
29	rs9975177	chr21:47517568-47517569	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs577250833	chr21:47517594-47517595	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs9680145	chr21:47517598-47517599	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs9680123	chr21:47517602-47517603	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs375925473	chr21:47517662-47517663	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs574844789	chr21:47517728-47517729	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
35	rs112836328	chr21:47517752-47517753	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs560810097	chr21:47517764-47517765	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs13047737	chr21:47517772-47517773	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs546361147	chr21:47517778-47517779	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
39	rs375135986	chr21:47517796-47517797	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
40	rs2277815	chr21:47517864-47517865	Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
41	rs2277816	chr21:47517869-47517870	Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs112531555	chr21:47518008-47518009	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
43	rs567827708	chr21:47518028-47518029	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
44	rs565698239	chr21:47518039-47518040	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
45	rs372628510	chr21:47518041-47518042	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
46	rs547100820	chr21:47518095-47518096	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
47	rs2277817	chr21:47518186-47518187	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs562300324	chr21:47518370-47518371	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
49	rs370685627	chr21:47518371-47518372	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
50	rs34972836	chr21:47518377-47518378	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:36)

Disease	PMID	Source
Down syndrome	17576883	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Autism	22958593	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Autism	18414403	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Breast cancer	17899364	CNVD
Prostate cancer	20473283	CNVD
Chordoma	18071362	CNVD
Cholangiocarcinoma	16830362	CNVD
Down syndrome	17334655	CNVD
Neuroticism	17667963	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Autoimmune polyendocrine syndrome	18200029	CNVD
Prostate cancer	19363497	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Olfactory neuroblastoma	18408657	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Multiple myeloma	16616336	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21509527	CNVD

Chromatin state (count:317 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:47485200-47517400	Weak transcription	Right Atrium	heart
2	chr21:47511400-47517600	Weak transcription	Pancreas	Pancrea
3	chr21:47513200-47517000	Weak transcription	Aorta	Aorta
4	chr21:47513200-47517200	Weak transcription	HSMM	muscle
5	chr21:47513200-47517200	Weak transcription	HSMMtube	muscle
6	chr21:47513400-47517000	Weak transcription	Muscle Satellite Cultured Cells	--
7	chr21:47513600-47517000	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
8	chr21:47514600-47518800	Weak transcription	Primary T killer memory cells from peripheral blood	blood
9	chr21:47515000-47517000	Enhancers	Spleen	Spleen
10	chr21:47515000-47517200	Weak transcription	Primary T helper naive cells from peripheral blood	blood
11	chr21:47515400-47517000	Enhancers	Right Ventricle	heart
12	chr21:47515600-47517000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
13	chr21:47515600-47517200	Transcr. at gene 5' and 3'	Foreskin Fibroblast Primary Cells skin02	Skin
14	chr21:47516400-47517000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
15	chr21:47516400-47517000	Bivalent Enhancer	Placenta	Placenta
16	chr21:47516400-47517400	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
17	chr21:47516400-47517800	Flanking Active TSS	Stomach Smooth Muscle	stomach
18	chr21:47516400-47519600	Bivalent/Poised TSS	Duodenum Smooth Muscle	Duodenum
19	chr21:47516600-47517000	Flanking Active TSS	Colon Smooth Muscle	Colon
20	chr21:47516600-47517000	Weak transcription	Ovary	ovary
21	chr21:47516600-47517000	Flanking Bivalent TSS/Enh	Rectal Smooth Muscle	rectum
22	chr21:47516600-47517200	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
23	chr21:47516600-47517200	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
24	chr21:47516600-47517200	Enhancers	Breast Myoepithelial Primary Cells	Breast
25	chr21:47516600-47517200	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
26	chr21:47516600-47517200	Bivalent Enhancer	Colonic Mucosa	Colon
27	chr21:47516600-47517200	Flanking Active TSS	NHDF-Ad	bronchial
28	chr21:47516800-47517000	Transcr. at gene 5' and 3'	IMR90 fetal lung fibroblasts Cell Line	lung
29	chr21:47516800-47517000	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
30	chr21:47516800-47517000	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
31	chr21:47516800-47517000	Flanking Active TSS	Adipose Nuclei	Adipose
32	chr21:47516800-47517000	Flanking Active TSS	Fetal Kidney	kidney
33	chr21:47516800-47517000	Bivalent Enhancer	Fetal Muscle Leg	muscle
34	chr21:47516800-47517000	Enhancers	Fetal Stomach	stomach
35	chr21:47516800-47517000	Flanking Bivalent TSS/Enh	Skeletal Muscle Female	skeletal muscle
36	chr21:47516800-47517200	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
37	chr21:47516800-47517200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
38	chr21:47516800-47517200	Flanking Bivalent TSS/Enh	Duodenum Mucosa	Duodenum
39	chr21:47516800-47517200	Bivalent/Poised TSS	Fetal Brain Male	brain
40	chr21:47516800-47517200	Flanking Bivalent TSS/Enh	Fetal Lung	lung
41	chr21:47516800-47517200	Bivalent/Poised TSS	Rectal Mucosa Donor 29	rectum
42	chr21:47516800-47517200	Bivalent/Poised TSS	Rectal Mucosa Donor 31	rectum
43	chr21:47516800-47517400	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
44	chr21:47516800-47517400	Flanking Active TSS	Osteobl	bone
45	chr21:47516800-47517600	Enhancers	Primary T helper naive cells fromperipheralblood	blood
46	chr21:47516800-47517600	Flanking Active TSS	NH-A	brain
47	chr21:47516800-47517600	Flanking Active TSS	NHLF	lung
48	chr21:47516800-47518000	Enhancers	Lung	lung
49	chr21:47516800-47518800	Bivalent/Poised TSS	Skeletal Muscle Male	skeletal muscle
50	chr21:47517000-47517200	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links